BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Checkpoint inhibitors
1
Implication of gut microbiome in immunotherapy for colorectal cancer
9/9/2022 12:48:14 PM | Browse: 527 | Download: 1555
2
Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach
7/27/2022 1:17:37 PM | Browse: 452 | Download: 1122
3
Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma
1/22/2022 6:17:12 AM | Browse: 592 | Download: 1225
4
Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
7/6/2019 6:23:58 AM | Browse: 1422 | Download: 2508
5
Checkpoint inhibitors: What gastroenterologists need to know
12/27/2018 8:56:32 AM | Browse: 918 | Download: 1563
6
Drug resistance and new therapies in colorectal cancer
9/14/2018 5:53:04 AM | Browse: 1259 | Download: 1785
7
Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors
8/8/2017 1:51:46 AM | Browse: 1131 | Download: 1895
8
Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality
5/6/2017 8:30:21 PM | Browse: 1138 | Download: 1772
9
From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis
2/8/2017 3:24:00 PM | Browse: 1182 | Download: 1794
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345